Astec Lifesciences Limited (ASTEC) Stock Statistics & Valuation Metrics

Astec Lifesciences Limited has a market cap or net worth of ₹19.53B. The enterprise value is ₹18.75B.

Astec Lifesciences Limited has 22,281,660 shares outstanding. The number of shares has decreased by -2.65% in one year.

Astec Lifesciences Limited’s return on equity (ROE) is -0.57 and return on invested capital (ROIC) is -14.59%.

The current PE Ratio of Astec Lifesciences Limited is ―. Astec Lifesciences Limited’s PEG ratio is ―.

In the last 12 months, Astec Lifesciences Limited had revenue of 3.81B and earned -1.35B in profits. Earnings per share was -68.71.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Astec Lifesciences Limited pays an annual dividend of ₹1.5, resulting in a dividend yield of 0.16%

Astec Lifesciences Limited upcoming earnings date is Oct 24, 2025, TBA (Confirmed).

Astec Lifesciences Limited as a current ratio of 0.93, with Debt / Equity ratio of 236.23%

In the past 12 months, Astec Lifesciences Limited has paid 62.77M in taxes.

Astec Lifesciences Limited EV to EBITDA ratio is -29.96, with an EV/FCF ratio of -65.64.

Astec Lifesciences Limited has ₹27.05M in cash and marketable securities with ₹5.55B in debt, giving a net cash position of ₹5.52B billion.

Gross margin is 24.16%, with operating margin of -28.95%, and net profit margin of -35.34%.

The average price target for Astec Lifesciences Limited is ₹838.00, which is 11.43% higher than the current price. The consensus rating is Hold